Reviewer Comment on Li et al. “Systematic Review: Mental Health Outcomes in Guillain–Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy”
Published online by Cambridge University Press:
19 May 2025
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Li, CMF, Wong, S, Fabiano, N, et al.Mental health outcomes in Guillain Barre Syndrome and chronic inflammatory demyelinating polyneuropathy. Can J Neurol Sci. 202510.1017/cjn.2025.10107CrossRefGoogle ScholarPubMed
2
Yalachkov, Y, Uhlmann, V, Bergmann, J, et al.Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance. PLoS One. 2020;15:e0228679.10.1371/journal.pone.0228679CrossRefGoogle ScholarPubMed
3
Lochmann, H, Wyrobnik, M, Kupper, C, et al.Theory of mind and executive dysfunction in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2024;31:e16053.10.1111/ene.16053CrossRefGoogle ScholarPubMed
4
Eyting, M, Xie, M, Michalik, F, et al.A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641:438–446.10.1038/s41586-025-08800-xCrossRefGoogle ScholarPubMed
Target article
Systematic Review: Mental Health Outcomes in Guillain–Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
Related commentaries (1)
Reviewer Comment on Li et al. “Systematic Review: Mental Health Outcomes in Guillain–Barre Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy”